ID

42528

Beskrivning

Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01091324

Länk

https://clinicaltrials.gov/show/NCT01091324

Nyckelord

Versioner (1)
  1. 2021-08-18 2021-08-18 -
Rättsinnehavare

National Cheng-Kung University Hospital

Uppladdad den

18 augusti 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Proteinuria NCT01091324

Engelsk

Eligibility Proteinuria NCT01091324

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min and and 0.5 g/day<proteinuria<3g/day.
Beskrivning

Chronic kidney disease stage | MDRD estimate | Proteinuria

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2074731
UMLS CUI [1,2]
C3839656
UMLS CUI [1,3]
C0033687
2. age between 18 and 75 years old.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
3. patients without hospitalization for cardiac or infection related morbidity over the previous 2 months(due to the potential confounding effects on baseline study variables).
Beskrivning

Recent hospitalization for cardiac morbidity absent | Recent hospitalization for infection related morbidity absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0018799
UMLS CUI [1,4]
C0332185
UMLS CUI [1,5]
C0332197
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0009450
UMLS CUI [2,4]
C0332185
UMLS CUI [2,5]
C0332197
4. patients who are able to provide consent to participate in the study.-
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients will significant mental illness, pregnant women, and other vulnerable populations.
Beskrivning

Significant mental illness | Pregnancy | Other vulnerable populations

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0750502
UMLS CUI [2]
C0032961
UMLS CUI [3,1]
C0949366
UMLS CUI [3,2]
C0205394
2. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
Beskrivning

Active hepatic disease | ALT mesurement increased

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205177
UMLS CUI [2,1]
C0201836
UMLS CUI [2,2]
C0442805
3. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
Beskrivning

History of congestive heart failure | NYHA classification

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0018802
UMLS CUI [1,3]
C1275491
UMLS CUI [1,4]
C1457887
4. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
Beskrivning

Patients for whom living donor renal transplantation is already scheduled or in the process of being evaluate

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C0348050
UMLS CUI [1,3]
C0205539
UMLS CUI [2,1]
C0022671
UMLS CUI [2,2]
C0348050
UMLS CUI [2,3]
C0220825
5. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
Beskrivning

Severe comorbidities

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
6. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
Beskrivning

Receiving immune modulating medications due to active inflammation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0678889
UMLS CUI [1,3]
C0021368
UMLS CUI [1,4]
C0205177
UMLS CUI [1,5]
C0678226
7. patients who are on corticosteroid therapy.
Beskrivning

Adrenal Cortex Hormones

Datatyp

boolean

Alias
UMLS CUI [1]
C0001617
8. patients who do not consent to participate in the study.
Beskrivning

Informed consent absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0332197
Tillbaka till toppen

Similar models

Eligibility Proteinuria NCT01091324

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Chronic kidney disease stage | MDRD estimate | Proteinuria
Item
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min and and 0.5 g/day<proteinuria<3g/day.
boolean
C2074731 (UMLS CUI [1,1])
C3839656 (UMLS CUI [1,2])
C0033687 (UMLS CUI [1,3])
Age
Item
2. age between 18 and 75 years old.
boolean
C0001779 (UMLS CUI [1])
Recent hospitalization for cardiac morbidity absent | Recent hospitalization for infection related morbidity absent
Item
3. patients without hospitalization for cardiac or infection related morbidity over the previous 2 months(due to the potential confounding effects on baseline study variables).
boolean
C0019993 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
C0332197 (UMLS CUI [1,5])
C0019993 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C0332185 (UMLS CUI [2,4])
C0332197 (UMLS CUI [2,5])
Informed consent
Item
4. patients who are able to provide consent to participate in the study.-
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Significant mental illness | Pregnancy | Other vulnerable populations
Item
1. patients will significant mental illness, pregnant women, and other vulnerable populations.
boolean
C0004936 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2])
C0949366 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
Active hepatic disease | ALT mesurement increased
Item
2. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
boolean
C0023895 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0201836 (UMLS CUI [2,1])
C0442805 (UMLS CUI [2,2])
History of congestive heart failure | NYHA classification
Item
3. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
boolean
C0262926 (UMLS CUI [1,1])
C0018802 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,4])
Patients for whom living donor renal transplantation is already scheduled or in the process of being evaluate
Item
4. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
boolean
C0022671 (UMLS CUI [1,1])
C0348050 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0022671 (UMLS CUI [2,1])
C0348050 (UMLS CUI [2,2])
C0220825 (UMLS CUI [2,3])
Severe comorbidities
Item
5. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Receiving immune modulating medications due to active inflammation
Item
6. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
boolean
C0013227 (UMLS CUI [1,1])
C0678889 (UMLS CUI [1,2])
C0021368 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,4])
C0678226 (UMLS CUI [1,5])
Adrenal Cortex Hormones
Item
7. patients who are on corticosteroid therapy.
boolean
C0001617 (UMLS CUI [1])
Informed consent absent
Item
8. patients who do not consent to participate in the study.
boolean
C0021430 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial